|
S&P 500 futures retreat after nearing record on Fed as Oracle disappointment drags down AI stocks: Live updates CNBCThe Fed's hawkish cut, Oracle earnings, Coca-Cola's next CEO and more in Morning Squawk CNBCWhy Oracle Is Worrying Investors About the A.I. Boom The New York TimesStock Dip-Buyers Step In After Oracle Spurs Slide: Markets Wrap Bloomberg.com
|
|
Dow jumps 600 points to record as Oracle sparks rush out of AI trade into broader market: Live updates CNBCWhy Oracle Is Worrying Investors About the A.I. Boom The New York TimesOracle Stock Is Getting Whacked. Is the AI Trade a 'Show Me Story' Now? InvestopediaOracle drags down Nvidia and other AI stocks as bubble fears intensify MarketWatch
|
|
Nasdaq slips as Oracle AI shock overshadows Fed relief ReutersOracle made a $300 billion bet on OpenAI. It's paying the price. Yahoo FinanceOracle shares tank 11%, dragging down Nvidia, CoreWeave, Micron CNBCHeard on the Street Recap: Oracle's Outlook The Wall Street Journal
|
|
Shares in the technology company are down as investors grow anxious that its bet on artificial intelligence, and OpenAI in particular, may not pay off.
|
|
Major Weight Loss and Knee-Pain Relief Seen With New Eli Lilly Drug The New York TimesEli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial cnbc.comEli Lilly Reports Dramatic Weight Loss in Next-Gen Obesity-Drug Trial The Wall Street JournalLilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief
|
|
